|
Index of reports
> Cases resulting in death (52)
> Cases with Blood Alkaline Phosphatase Increased (8)
Below is the selection of adverse event reports related to Diovan (Valsartan) that includes cases resulting in death where reactions include blood alkaline phosphatase increased.
Adverse event in 62 year old female receiving Diovan (Valsartan)
Reported by a individual with unspecified qualification from Japan on 2007-07-27
Patient: 62 year old female
Adverse reactions / side effects: Myoglobinuria, Blood Creatine Phosphokinase Increased, Rhabdomyolysis, Disseminated Intravascular Coagulation, Intubation, Hyperthermia Malignant, Pyrexia, Multi-Organ Failure, PO2 Decreased, Incontinence, Hypokinesia, C-Reactive Protein Increased, Dialysis, Musculoskeletal Stiffness, Blood Creatinine Increased, White Blood Cell Count Increased, Renal Failure Acute, Blood Alkaline Phosphatase Increased, Blood Pressure Increased, Metabolic Acidosis, Blood Urea Increased, Blood Lactate Dehydrogenase Increased, International Normalised Ratio Increased, Alanine Aminotransferase Increased, Respiratory Rate Decreased, Aspartate Aminotransferase Increased, Dehydration, Heart Rate Increased, Oliguria, Platelet Count Decreased, Depressed Level of Consciousness, Gait Disturbance, Blood Pressure Decreased
Adverse event resulted in: death
Suspect drug(s):
Biofermin
Administration route: Oral
Start date: 2006-07-18
End date: 2006-07-19
Diovan
Dosage: unk, unk
Administration route: Oral
Start date: 2003-01-01
Diovan
Dosage: 40 mg/day
Administration route: Oral
Start date: 2006-07-10
End date: 2006-07-19
Loxonin
Dosage: 60 mg/day
Administration route: Oral
Start date: 2006-07-18
End date: 2006-07-19
Mucosta
Dosage: 100 mg/day
Administration route: Oral
Start date: 2006-07-18
End date: 2006-07-19
Adverse event in 67 year old female receiving Diovan (Valsartan)
Reported by a individual with unspecified qualification from Japan on 2007-07-23
Patient: 67 year old female
Adverse reactions / side effects: Myoglobinuria, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Intubation, Disseminated Intravascular Coagulation, Hyperthermia Malignant, Pyrexia, PO2 Decreased, Multi-Organ Failure, Hypokinesia, Incontinence, C-Reactive Protein Increased, Musculoskeletal Stiffness, Blood Creatinine Increased, Renal Failure Acute, White Blood Cell Count Increased, Blood Pressure Increased, Blood Alkaline Phosphatase Increased, Blood Urea Increased, Metabolic Acidosis, Alanine Aminotransferase Increased, International Normalised Ratio Increased, Blood Lactate Dehydrogenase Increased, Respiratory Rate Decreased, Oliguria, Heart Rate Increased, Aspartate Aminotransferase Increased, Dehydration, Platelet Count Decreased, Depressed Level of Consciousness, Gait Disturbance, Blood Pressure Decreased
Adverse event resulted in: death
Suspect drug(s):
Diovan
Dosage: unk, unk
Administration route: Oral
Indication: Hypertension
Diovan
Dosage: 40 mg/day
Administration route: Oral
Start date: 2006-07-10
End date: 2006-07-19
Adverse event in 82 year old male receiving Diovan (Valsartan)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-20
Patient: 82 year old male, weighing 88.9 kg (195.6 pounds)
Adverse reactions / side effects: Metastatic Neoplasm, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Bile Duct Cancer
Adverse event resulted in: death, disablity
Suspect drug(s):
Diovan (Valsartan)
Other drugs received by patient: Lasix; Vitamin B-12; Aspirin; Alopurinol
Adverse event in 67 year old female receiving Diovan (Valsartan)
Reported by a individual with unspecified qualification from Japan on 2007-06-11
Patient: 67 year old female
Adverse reactions / side effects: Myoglobinuria, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Intubation, Disseminated Intravascular Coagulation, Hyperthermia Malignant, Pyrexia, PO2 Decreased, Multi-Organ Failure, Hypokinesia, Incontinence, C-Reactive Protein Increased, Musculoskeletal Stiffness, Blood Creatinine Increased, Renal Failure Acute, White Blood Cell Count Increased, Blood Pressure Increased, Blood Alkaline Phosphatase Increased, Blood Urea Increased, Metabolic Acidosis, Alanine Aminotransferase Increased, International Normalised Ratio Increased, Blood Lactate Dehydrogenase Increased, Respiratory Rate Decreased, Oliguria, Heart Rate Increased, Aspartate Aminotransferase Increased, Dehydration, Platelet Count Decreased, Depressed Level of Consciousness, Gait Disturbance, Blood Pressure Decreased
Adverse event resulted in: death
Suspect drug(s):
Diovan
Administration route: Oral
Indication: Hypertension
Diovan
Dosage: 40 mg/day
Administration route: Oral
Start date: 2006-07-10
End date: 2006-07-19
Adverse event in 76 year old male receiving Diovan (Valsartan)
Reported by a pharmacist from Japan on 2007-03-05
Patient: 76 year old male
Adverse reactions / side effects: Choking Sensation, PO2 Decreased, Interstitial Lung Disease, C-Reactive Protein Increased, Palpitations, Tracheostomy, Blood Bicarbonate Increased, Cell Marker Increased, Acute Respiratory Failure, White Blood Cell Count Increased, Oxygen Saturation Decreased, Blood Alkaline Phosphatase Increased, Dyspnoea, Blood Lactate Dehydrogenase Increased, Lung Disorder, Hypertension, Inflammation
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Diovan (Valsartan)
Other drugs received by patient: Adalat; Actos; Lasix
Adverse event in 76 year old male receiving Diovan (Valsartan)
Reported by a pharmacist from Japan on 2007-02-27
Patient: 76 year old male
Adverse reactions / side effects: Choking Sensation, PO2 Decreased, Interstitial Lung Disease, C-Reactive Protein Increased, Palpitations, Tracheostomy, Blood Bicarbonate Increased, Cell Marker Increased, Acute Respiratory Failure, White Blood Cell Count Increased, Oxygen Saturation Decreased, Blood Alkaline Phosphatase Increased, Dyspnoea, Blood Lactate Dehydrogenase Increased, Lung Disorder, Hypertension, Inflammation
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Diovan (Valsartan)
Other drugs received by patient: Adalat; Actos; Lasix
Adverse event in 76 year old male receiving Diovan (Valsartan)
Reported by a pharmacist from Japan on 2007-02-19
Patient: 76 year old male
Adverse reactions / side effects: Choking Sensation, PO2 Decreased, Interstitial Lung Disease, C-Reactive Protein Increased, Palpitations, Tracheostomy, Blood Bicarbonate Increased, Acute Respiratory Failure, Cell Marker Increased, Oxygen Saturation Decreased, White Blood Cell Count Increased, Blood Alkaline Phosphatase Increased, Dyspnoea, Blood Lactate Dehydrogenase Increased, Lung Disorder, Hypertension, Inflammation
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Actos
Dosage: 15 mg/day
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2005-08-29
End date: 2006-10-16
Adalat
Dosage: 40 mg/ day
Administration route: Oral
Indication: Hypertension
Start date: 2005-08-29
End date: 2006-10-16
Diovan
Dosage: 80 mg, tid
Administration route: Oral
Indication: Hypertension
Start date: 2005-08-25
End date: 2006-10-16
Lasix
Dosage: 20 mg/day
Administration route: Oral
Indication: Hypertension
Start date: 2005-08-29
End date: 2006-10-16
Adverse event in 76 year old male receiving Diovan (Valsartan)
Reported by a physician from Japan on 2007-02-12
Patient: 76 year old male
Adverse reactions / side effects: Choking Sensation, PO2 Decreased, Palpitations, Interstitial Lung Disease, Tracheostomy, Blood Bicarbonate Increased, Cell Marker Increased, Acute Respiratory Failure, White Blood Cell Count Increased, Oxygen Saturation Decreased, Blood Alkaline Phosphatase Increased, Dyspnoea, Blood Lactate Dehydrogenase Increased, Lung Disorder, Hypertension, Inflammation
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Diovan (Valsartan)
Other drugs received by patient: Adalat; Actos; Lasix
|
